Back to Archived Journals » Core Evidence » Volume 2 » Issue 4

Review

Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration

       
Total article views   HTML views PDF downloads Totals
8,271 Dovepress* 8,271+ 2,287 10,558
Totals 8,271 2,287 10,558
*Since 15 December 2007
+Since July 2016

View citations on Google Scholar